United Therapeutics Corp UTHR
News
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
United Therapeutics Corporation to Present at Upcoming Investor Conferences
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
Miromatrix Medical stock soars after it agrees to be bought by United Therapeutics